FDAClass II · Drug · Recalled July 1, 2026

Perampanel CIII Tablets recall — SUN PHARMACEUTICAL INDUSTRIES INC

Hazard: Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID: D-0628-2026
Brand: SUN PHARMACEUTICAL INDUSTRIES
Classification: Class II
Units affected: 3,456 30-count bottles
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Description

Perampanel CIII Tablets, 6mg, Rx only, 30 Tablets, Mfd.by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 51672-4206-6

Affected products

Perampanel CIII Tablets

Companies & origin

Recalling firm location: Princeton, NJ, United States
Firm address: 2 Independence Way, N/A, 08540-6620

Identifying details (verbatim from the notice)

Product codes / lots: Lot AE01763, Expires 9/30/2027.
Distribution: Nationwide in the USA
Firm notified the public via: Letter
FDA event ID: 99256
Recall initiated: June 17, 2026
FDA classified: June 26, 2026
FDA report date: July 1, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 24, 2026 at 12:00 AM UTC.

Report a data error on this page